Bellerophon Therapeutics Revenue, Growth & Competitor Profile

DBA BELLEROPHON
DBA BELLEROPHON PULSE TECHNOLOGIES LLC
DBA BELLEROPHON SERVICES, INC.

Company Profile & Annual Report for Bellerophon Therapeutics

Access the complete profile.

Bellerophon Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	184 Liberty Corner Rd Ste 302 Warren, NJ 07059

Bellerophon Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bellerophon Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Bellerophon Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Bellerophon Therapeutics is a publicly traded company on NGM using the ticker symbol BLPH. Detailed information on company financials and operating reports can be found here: NGM: BLPH

Bellerophon Therapeutics Annual Revenue and Growth Rate

Bellerophon Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bellerophon Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Bellerophon Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 11, 2017	11	100%	$23 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Bellerophon Therapeutics is developing and marketing. Bellerophon Therapeutics doesn't have any recent trademark applications, indicating Bellerophon Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
INOPEAK Medical devices for use in connection with the delivery of pharmaceutical gases for the treatment of lung infections	01/09/2020
INOVATION Conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials	08/11/2017
INOVATION INO Conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials	08/11/2017

See all trademarks and details in the Full Report.

Market Share of Bellerophon Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bellerophon Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Bellerophon Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SOLVIAS	Fort Lee, NJ	100
HISENSE PHOTONICS	South Plainfield, NJ	46
PACIRA THERAPEUTICS	Parsippany, NJ	35
PANDION THERAPEUTICS	Rahway, NJ	25
ELEVAR THERAPEUTICS	Fort Lee, NJ	21
MAXENTRIC TECHNOLOGIES	Fort Lee Borough, NJ	16

Future Competition: Bellerophon Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Bellerophon Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)